Obesity, gastroesophageal reflux, and smoking have repeatedly been shown to be important and independent risk factors for adenocarcinoma of the esophagus (EAC) and of the gastroesophageal junction (GEJAC). There have been few attempts, however, to quantify the proportion of disease associated with these potentially modifiable factors. The authors have estimated the population attributable fraction of EAC and GEJAC attributable to obesity, symptoms of gastroesophageal reflux, and smoking using data from a population-based case-control study conducted in Australia between 2002 and 2005. Cases were patients with EAC (n ¼ 364) or GEJAC (n ¼ 425). Controls (n ¼ 1,580) were randomly sampled from a population register. Combinations of smoking, body mass index (weight in kilograms divided by height in meters squared), and gastroesophageal reflux together accounted for 76% (95% confidence interval: 66, 84) of EAC cases and 69% (95% confidence interval: 58, 78) of GEJAC cases. Individually, high body mass index (!30) and frequent acid reflux (!1 time/week) accounted for the greatest proportions of EAC (23% and 36%, respectively), and smoking and frequent symptoms of acid reflux accounted for the greatest proportions of GEJAC (43% and 28%, respectively). The present study suggests that these cancers may be largely prevented by maintaining healthy body mass index, avoiding smoking, and controlling symptomatic gastroesophageal reflux. esophageal adenocarcinoma; esophagogastric junction; esophagus; gastroesophageal reflux; obesity; smoking Abbreviations: BMI, body mass index; CI, confidence interval; EAC, adenocarcinoma of the esophagus; GEJAC, adenocarcinoma of the gastroesophageal junction; GER, gastroesophageal reflux; PAF, population attributable fraction.
The rates of adenocarcinomas of the esophagus (EAC) and the gastroesophageal junction (GEJAC) are increasing in many countries worldwide (1) (2) (3) (4) , particularly among men. These consistent increases in incidence across populations in the absence of notable changes in methods of detection and diagnosis (5, 6 ) strongly implicate nongenetic factors as the underlying causes of these cancers. Obesity, gastroesophageal reflux (GER), and smoking have repeatedly been shown to be important and independent risk factors for both EAC and GEJAC (7) (8) (9) (10) , and there is evidence of biologic interaction between obesity and GER (11) in the etiology of these cancers. A necessary next step is to quantify the burden of disease associated with these potentially modifiable factors to quantify the public health impact of prevention strategies.
Population attributable fractions (PAFs) are useful in assessing the impact of disease risk factors in a given population, as they take into account both the strength of the association and the prevalence of each factor in the population. A risk factor strongly associated with the disease but with low prevalence in the population will have less of a public health impact than will a risk factor with a similar effect that affects a large proportion of the population. A single risk factor approach is most often used in the calculation of PAFs; however, it can lead to some challenges in interpretation because the resulting PAFs do not take into account the possible interaction of multiple competing risks (12) . Partial PAFs present the risk estimates for combinations of common risk factors so that additive effects can be explored (13) .
To our knowledge, only 1 study has examined the PAFs for risk factors associated with EAC and GEJAC (14) , and these PAFs were calculated from data from a populationbased case-control study conducted in the United States from 1993 to 1995. Engel et al. (14) reported high PAFs for former and current smoking, high body mass index (BMI), and high frequency of GER symptoms. They reported PAFs for single risk factors that were adjusted for all other factors; however, they did not calculate PAFs for combinations of these factors, some of which are known to be highly correlated. For diseases with multifactorial causes, analyses that do not examine risk-factor combinations could overestimate or underestimate the PAFs associated with individual risk factors (15) , as causative factors often co-occur and interact to greater or lesser degrees.
With an aim to quantify the theoretical scope for prevention of these diseases in the population, we computed PAFs of EAC and GEJAC associated with BMI, smoking, and GER by using data from a case-control study conducted in Australia between 2002 and 2005 (11) . We extended previous analyses by calculating partial PAFs for combinations of the major risk factors. Partial PAFs can indicate the relative importance of risk-factor combinations and help set priorities for public health prevention efforts.
MATERIALS AND METHODS

Study participants
The methods used in the Australia-wide population-based case-control study have been described previously (11) . Eligible cases were people aged 18-79 years who lived in Australia and had a histologically confirmed primary invasive cancer of the esophagus or gastroesophageal junction diagnosed between July 1, 2002, and June 30, 2005, in Queensland. Cases were recruited through either major treatment centers or state cancer registries. Of the 1,577 patients with esophageal cancer invited to participate in the study (1, 191 through clinics and 386 through cancer registries), 1,102 patients (70%) returned a completed questionnaire (367 EAC cases and 426 GEJAC cases; 309 esophageal squamous cell carcinoma cases were excluded from these analyses). Three EAC cases and 1 GEJAC case were deemed ineligible on review and were also excluded from these analyses, leaving a total of 364 EAC cases and 425 GEJAC cases.
Controls were randomly selected from the national electoral roll and were frequency-matched by age (in 5-year age bands) and state of residence to the case group. Of 3,258 
Exposure measurement
Information was collected using a self-administered questionnaire, which included questions about demographic, medical, hormonal, reproductive, dietary, family history, and other potential risk factors. Exposures were assessed before a reference date, defined as 1 year before the date of diagnosis (or date of first approach for controls), because more recent exposures in cases could have been influenced by the presence of subclinical disease. Participants selfreported height and weight 1 year before the date of diagnosis. Participants were asked about frequency of heartburn (described as ''a burning pain behind the breastbone after eating'') or acid reflux (described as ''a sour taste from acid or bile rising up into the mouth or throat'') in the 10 years before diagnosis and frequency of aspirin or nonsteroidal antiinflammatory drug use in the past 5 years. Detailed questions about past and current smoking habits asked participants whether, over their whole lives, they had ever smoked more than 100 cigarettes, cigars, or pipes; positive responses elicited further questions about the ages at which they started and stopped smoking and about typical daily consumption.
BMI, calculated as weight in kilograms divided by height in meters squared, was classified using the World Health Organization definitions of obesity (underweight: <18.5; normal weight: 18.5-24.9; overweight: 25-29.9; class I obesity: 30-34.9; class II obesity: 35-39.9; and class II obesity: !40) (16) . In the present analysis, smokers were categorized as never smokers or ever smokers. Frequency of acid reflux symptoms was defined as the highest reported frequency of either heartburn or acid reflux and was categorized as never, less than weekly, and once or more per week.
Statistical methods
To calculate adjusted PAFs with 95% confidence intervals, we used the method of Bruzzi et al. (12) , which uses adjusted odds ratios from unconditional logistic regression and prevalence of the risk factors in the study cases. This method takes into account multiple levels of exposure and controls for confounding. Confidence intervals for the model-based PAFs were calculated using logit transformation as described by Benichou and Gail (17) , except in cases in which the PAF was negative, in which case the confidence intervals were calculated as PAF 6 1.96 3 standard error, using the same approach as Engel et al. (14) . First, PAFs were calculated for individual risk factors for all cases and separately for men and women. We estimated relative risks associated with each stratum of smoking, BMI, and acid reflux symptoms and adjusted for age, sex, educational level, and the other 2 main variables of interest. For smoking and acid reflux symptoms, the ''never'' category was used as the reference category; for BMI, normal weight was used as the reference category. We computed partial PAFs for combinations of smoking status, BMI, and frequency of acid reflux symptoms using 2 strata of smoking (never smokers vs. ever smokers) and BMI (<25 vs. !25) and 3 strata of frequency of acid reflux symptoms (never, less than weekly, or once or more per week). We computed PAFs for all cases and adjusted them for age, sex, educational level, and nonsteriodal antiinflammatory drug use; we then computed them separately for men and women. The reference group for comparison was people in the normal weight range who had never smoked and had not reported symptoms of acid reflux in the relevant time period. The partial PAF presented here is the reduction in risk that would result from setting 1 exposure category in the cross-classification of exposure factors to the lowest level of risk while holding confounders and other joint exposure levels constant. The sum of the partial attributable risks across all joint cross-classifications of the exposure variables would be the PAF.
All analyses were conducted using the Interactive Risk Assessment Program, version 2.2 (available from the National Institutes of Health; http://dceg.cancer.gov/bb/tools/ irap). Statistical significance was determined at a ¼ 0.05, and all tests for statistical significance were 2-sided. Comparison of PAFs between men and women in each subset was performed using an independent t test.
RESULTS
The characteristics of study cases and controls are presented in Table 1 . Of the 364 patients with EAC, 329 (90%) were men and 35 (10%) were women. Of the 425 patients with GEJAC, 369 (87%) were men and 56 (13%) were women. As reported previously, both case groups were more likely than controls to be ever smokers, to be in the overweight or obese range of BMI, and to report frequent symptoms of acid reflux (11, 18) .
PAFs for individual risk factors
EAC. The PAFs of EAC for the individual risk factors but adjusted for the other factors are presented in Table 2 . For all cases combined, we found that symptoms of acid reflux contributed the highest PAF (49%, 95% confidence interval (CI): 38, 60), which was greater for men than for women (50% and 26%, respectively), although not significantly so (P ¼ 0.15). A high proportion of EAC was attributable to overweight and obesity in men but not in women (PAF ¼ 41% (95% CI: 27, 57) for men vs. 4% (95% CI: 0, 100) for women), although again this failed to reach statistical significance (P ¼ 0.07). In contrast, a greater proportion of EAC cases was attributable to a history of ever smoking in women (46%, 95% CI: 23, 71) than in men (26%, 95% CI: 12, 45), but again not significantly so (P ¼ 0.10). The negative PAFs observed for overweight women and women with low levels of GER are based on small numbers of cases (n ¼ 7 and n ¼ 8, respectively), and the imprecision is reflected in the wide confidence intervals. These estimates are unlikely to have an impact on disease at the population level.
GEJAC. In patients with GEJAC, we found that more cancers were attributable to ever smoking (43%, 95% CI: 32, 54) than to any other single factor, and the proportions were similar for men and women (41% and 46%, respectively) (Table 3 ). Similar to the pattern seen for EAC, a nonsignificantly higher proportion of GEJAC cases was attributable to GER for men (PAF ¼ 36%, 95% CI: 25, 50) than for women (PAF ¼ 16%, 95% CI: 2, 67) (P ¼ 0.12). In contrast, a higher proportion of GEJAC was attributable to overweight and obesity in women (PAF ¼ 33%, 95% CI: 11, 66) than in men (PAF ¼ 18%, 95% CI: 6, 42), but again this was not a significant difference (P ¼ 0.21).
Partial PAFs for combinations of risk factors
EAC. Partial PAFs for combinations of exposure to smoking, BMI, and symptoms of GER are presented in Table 4 . The total PAF associated with all combinations of these 3 factors in the population was 76% (95% CI: 66, 84), and it was higher for men (78% for men vs. 59% for women), although the difference was not significant (P ¼ 0.15). The highest partial PAF observed was among those with all 3 factors co-occurring, that is, being overweight or obese, having a history of smoking, and reporting acid reflux symptoms as occurring at least weekly (25%, 95% CI: 21, 30). Among cases who were never smokers, the highest PAFs were noted for overweight or obese people with frequent GER symptoms (8%, 95% CI: 6, 11).
GEJAC. The total PAF of GEJAC associated with all combinations of smoking, BMI, and symptoms of GER was of a magnitude similar to that of EAC (69%, 95% CI: 58, 78) c P < 0.05 comparing population attributable fractions for men and women using an independent t test.
and was equal for men and women (Table 5) . Individual contributions of the 3 factors to the total PAF followed patterns similar to those seen for EAC, although among nonsmokers, high BMI had a lower PAF for GEJAC than for EAC.
DISCUSSION
We have estimated the PAFs of EAC and GEJAC for 3 risk factors individually and in combination. The PAF estimates the proportion of disease that can be attributed to a risk factor or groups of risk factors and thus the proportion of cases that might be avoided if those factors were eliminated from the population. Because many risk factors for multifactorial disease co-occur and/or interact, it is important to examine the combined effects of those factors. Overall, overweight and obesity, smoking, and frequent GER present in various combinations in people accounted for 76% of EAC cases and 69% of GEJAC cases, with high BMI and frequent symptoms of GER individually accounting for the greatest proportion of EAC, and smoking and frequent symptoms of GER individually accounting for the greatest proportion of GEJAC. When we examined the factors in different combinations, the highest proportion of disease was associated with being simultaneously overweight or obese and a smoker with frequent symptoms of acid reflux. The co-occurrence of these 3 factors may explain 25% of all cases of EAC. All 3 factors accounted for the same proportion of GEJAC disease in men and women (68%), but for EAC, the proportion of disease explained by these factors was lower for women than for men (59% vs. 76%). However, this difference was not statistically significant. The apparent differences in PAFs between the sexes may reflect real differences in esophageal cancer biology between men and women, although our ability to infer is constrained by the small number of affected women in our sample. It is possible that other sources of bias could be operating, such as systematic misclassification and selection bias, but why these should introduce sex-specific differences in effect is not clear. Combining these data with those from other, similar studies would be one means of obtaining more precise sex-specific estimates of PAF.
To our knowledge, no investigators have previously reported PAFs of EAC for combinations of risk factors. In a previous study, Engel et al. (14) estimated PAFs due to smoking, high BMI, and high frequency of GER symptoms in a US population. Those investigators reported proportions of disease attributable to high BMI of similar magnitude as those reported here; however, frequent symptoms of GER had PAFs that were lower for men and higher for women than in our Australian population (28% in Australia vs. 50% in the United States for men; 40% in Australia vs. 26% in the United States for women). The proportion of disease attributable to both current and former smoking was higher for women in our Australian study. The PAF considers both the strength of association between risk factor and outcome and the prevalence of the factor in the community, which may vary over time and between populations. Thus, differences in PAFs between populations will reflect the different prevalence rates of risk factors in the populations. Although sex-specific prevalence data were not available for the study by Engel et al. (14) , the prevalence of smoking for men and women overall (current or past) was lower in our Australian control population than in the US study (14) (55% vs. 67%), mostly because of a lower prevalence of current smoking (13% vs. 22%). The prevalences of overweight/obesity and symptoms of GER, however, were higher in our Australian population: 64% were overweight or obese compared with 51% in the US study population, and 56% reported any symptoms of GER compared with 47% in the US study population. The data used for the US study were collected more than 15 years ago, however, and the prevalences of obesity and reflux have increased since that time (19, 20) , whereas the prevalence of smoking has declined (21) .
Although the prevalence of smoking in Australia has declined since the 1950s and this trend is expected to continue (22) , concomitant increases in the prevalence of obesity, particularly the higher levels of obesity (23) , suggest that the benefits gained from declining smoking rates may be outweighed by the negative effects of increasing levels of obesity. During the period 1980-2007, the prevalence of current smoking in Australia decreased by approximately 19% for men and 11% for women (22) . Over the same period , the prevalence of obesity (BMI !30) doubled and the prevalence of class III obesity (BMI !40) increased 4-fold (24) . These increases parallel increases in the prevalence of GER (25) . Thus, if current trends continue unabated, we might expect that the incidence of these cancers in Australia will continue to rise.
Strengths of our study included the population-based design, large number of cases, and detailed information on multiple exposures. A limitation was the relatively low participation rate among controls (49%), which could have resulted in selection bias and an overrepresentation of more health-conscious control participants who were less likely to be overweight or obese. However, the demographic characteristics of our participating controls were similar to those of the participants in the Australian National Health Survey, a representative survey of the Australian adult population conducted in 2004 (26) . We have also previously explored the potential for selection bias due to nonparticipation on risk estimates for smoking and BMI. We compared odds ratios derived from self-reported data from participating controls with odds ratios derived using imputed data for nonparticipating controls; we observed only a modest level of attenuation in risk estimates among current smokers and no evidence of bias for associations with BMI (27) . The prevalence of at least weekly symptoms of reflux in our population sample of controls (12% among men and 11% among women; Table 1 ) was similar to prevalence estimates from other population surveys in Australia (28), the United Kingdom (29) , and Sweden (30) . We therefore consider the likelihood of biased selection on the basis of this symptom to be no greater than for previous studies.
Our analyses relied on retrospective self-reported height and weight. Recall of body weight and height can be subject to misclassification, although we observed high levels of repeatability for these measures in this study (31) . Both men and women tend to overreport their height; men tend to overestimate their weight, but women, particularly younger women, underreport their weight (32) . Thus, BMI is more often underestimated for women than for men. Such nondifferential misclassification would lead to an attenuation of the true association with obesity and an underestimate of the PAF. Lastly, these estimates of PAF assume that there is a causal association between each factor and esophageal cancer and that removal of exposure to these factors alone will lead to a decline in incidence of esophageal cancer. It is possible, however, that there are other causal factors that are correlated with the factors examined here and that would continue to exert a force of morbidity even if these primary factors were removed. Although that is possible, our prior analyses suggest that the potential role of other factors is much less than the factors examined here.
In summary, 3 largely modifiable risk factors occurring in various combinations explained more than two-thirds of the cases of EAC and GEJAC in this Australian population, making these diseases largely preventable through maintenance of a healthy BMI, avoidance of smoking, and elimination symptomatic GER from the population.
